Clinical trial Recruiting at 1 site Observational Ages 18 and up

Investigating brain activity related to walking in Parkinson's patients

Official title: Investigating Neural Biomarkers for Gait in Parkinson's Patients

Run by Swiss Federal Institute of Technology · NCT05820074 · Data updated 2026-11-12

This study looks at how the brains of people with Parkinson's disease work while they walk to see if it can help create better treatments for their movement problems.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment60 (estimated)
SponsorSwiss Federal Institute of Technology
Academic / other
Locations1 site (Vitznau, Canton of Lucerne)
StatusRecruiting
StartedApril 13, 2023
Main results expectedMarch 2025
Study endsMarch 2025
Registry record updatedDecember 3, 2024
Trial IDNCT05820074 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include non-tremor dominant idiopathic Parkinson's patients with postural instability and gait disturbances who have an implanted Percept™ PC neurostimulator.

Probably not a fit

Patients with relevant cognitive impairments or those with other neurological or orthopedic conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to explore the neural mechanisms involved in movement among individuals with Parkinson's disease. Participants will engage in walking and gait-related tasks while their brain activity is recorded to identify neural biomarkers associated with gait. The study includes 60 participants, split evenly between healthy individuals and those with Parkinson's disease, to compare neural activity during different motor tasks. Insights gained may lead to personalized treatment options for managing gait disorders in Parkinson's patients.

Why it matters

Potential benefit: If successful, this study could lead to more personalized and effective treatment strategies for gait disorders in Parkinson's disease.

How similar studies have gone: Other studies have shown promise in identifying neural biomarkers for movement disorders, suggesting that this approach may yield valuable insights.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

All participants

* must have given informed consent as documented by signature
* agree to comply with the study procedures

Healthy control group

* no neurological, orthopedic, or rheumatologic disease history
* no identified sensory impairment.
* no epilepsy and self-diagnosed acute or chronic psychiatric disorders

Parkinson's Patients

* non-tremor dominant idiopathic PD patients
* presence of postural instability (UPDRS \>1 for postural instability \[17\]), gait disturbance, and absence of other causes of reduced balance
* Implanted with Percept™ PC neurostimulator
* Able to be in the stimulation OFF

Exclusion Criteria:

* Relevant cognitive impairment, with a score on Montréal Cognitive Assessment (MoCA) \< 20
* History of physical or neurological condition that interferes with study procedures
* Social and/or personal circumstances interfering with the ability to come to the session

Where it's running

  • Cereneo
    Vitznau, Canton of Lucerne, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.